Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Cancer Biology & Medicine|January 19, 2016
Bridging academic science and clinical research in the search for novel targeted anti-cancer agentsAlex MatterDrug Discovery Today|April 15, 2008
Impact of non-profit organizations on drug discovery: opportunities, gaps, solutionsAlex Matter, Thomas H KellerCurrent Opinion in Cell Biology|February 28, 2009
Protein kinases as antibacterial targetsMark Schreiber, Ivica Res, Alex MatterCurrent Opinion in Pharmacology|July 20, 2002
Protein tyrosine kinase inhibitors: new treatment modalities?Doriano Fabbro, David Parkinson, Alex MatterNature Reviews. Drug Discovery|July 18, 2002
Glivec (STI571, imatinib), a rationally developed, targeted anticancer drugRenaud Capdeville, Elisabeth Buchdunger, Juerg Zimmermann, et al.Heart Failure Reviews|May 9, 2018
Drugs' development in acute heart failure: what went wrong?Vincenzo Teneggi, Nithy Sivakumar, Deborah Chen, et al.Nature|August 8, 2020
Rescue of oxytocin response and social behaviour in a mouse model of autismHanna Hörnberg, Enrique Pérez-Garci, Dietmar Schreiner, et al.Vaccine|July 22, 2014
Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteersJenny G H Low, Lawrence S Lee, Eng Eong Ooi, et al.Clinical and Translational Science|July 26, 2019
First-in-Human, Healthy Volunteers Integrated Protocol of ETC-206, an Oral Mnk 1/2 Kinase Inhibitor Oncology DrugVincenzo Teneggi, Veronica Novotny-Diermayr, Lay Hoon Lee, et al.Cancer Research|January 22, 2026
ETC-501 is a Brain Penetrant MNK Kinase Inhibitor that Potentiates TMZ-Induced Senescence and Sensitizes Glioblastoma Cells to Senolytic TherapyGiselle Sek Suan Nah, Yuk Kien Chong, Fatin Nasha Sulaimi, et al.Pageof 2